All In Biotech

Drug Trial Radar · NCT07864207

Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jul 28, 2026

Primary completion

Jul 30, 2028

Study completion Jul 30, 2028

Sponsor

Lead sponsor
IDP Discovery Pharma S.L.Industry
Sponsor type
Industry
First posted
Oct 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 1/2 clinical trial is to evaluate the safety, pharmacokinetics and pharmacodynamics of escalating doses of IDP-121 combined with chemotherapy in patients with advanced unresectable/metastatic SCLC that have progressed after 1st line platinum- based chemotherapy, considering the role of MYC amplification in the development of platinum resistance.

Conditions

  • Small Cell Lung Cancer ( SCLC )

Interventions

  • IDP-121Drug

    IDP-121

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MTD and RP2DTime frame: 1 year

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital del Mar

    Barcelona, Spain · Not yet recruiting

  • ICO Badalona Germans trias i Pujol

    Barcelona, Spain · Not yet recruiting

  • Hospital Universitario Gran Canaria

    Las Palmas de Gran Canaria, Spain · Not yet recruiting

  • Clinica Universidad de Navarra (CUN)

    Madrid, Spain · Recruiting

  • Hospital Regional Universitario de Málaga

    Málaga, Spain · Recruiting

  • Hospital Universitario Virgen de la Arrixaca

    Murcia, Spain · Recruiting

  • Clinica Universidad de Navarra (CUN)

    Pamplona, Spain · Recruiting

  • Hospital Universitario de Navarra

    Pamplona, Spain · Recruiting

  • Hospital Universitario Nstra Señora de Candelaria

    Santa Cruz de Tenerife, Spain · Not yet recruiting

  • Hospital Clínico de Valencia

    Valencia, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.